Prognostic significance of c-erbB-2 mRNA in ovarian carcinoma

Gynecologic Oncology

Volumn 62, Issue 2, 1996, Pages 268-277

  Tanner, Berno ^a   Kreutz, Elisabeth ^a   Weikel, Wolfgang ^a   Meinert, Rolf ^a   Oesch, Franz ^a   Knapstein, Paul Georg ^a   Becker, Roger ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; MESSENGER RNA;

ABDOMINAL HYSTERECTOMY; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; ONCOGENE C ERB; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; SURVIVAL TIME;

EID: 0030220590     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0226     Document Type: Article

References (39)

1. 1. Schechter, A. L., Hung, M. C., Vaidyanathan, L., Weinberg, T. L., Yang-Feng, T. L., Francke, U., Ullrich, A., and Coussens, L. The neu gene: An erb-homologous gene distinct and unlinked to the gene encoding the EGF-receptor, Science 229, 976-978 (1985).
2. 2. Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, A., Ullrich, J., Schlesinger, M., and Waterfield, D. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences, Nature 307, 521-527 (1984).
3. 3. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor, Nature 319, 230-234 (1986).
4. 4. Lupu, R., Colomer, R., Zugmaier, G., Sarup, J., Shepard, M., Slamon, D. J., and Lippman, M. E. Direct interaction of a ligand for the cerbB2 oncogene product with the EGF receptor and p185erbB2, Science 249, 1552-1555 (1990).
5. 5. Yarden, Y., and Peles, E. Biochemical analysis of the ligand for the neu oncogenic receptor, Biochemistry 30, 3543-3550 (1991).
6. 6. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. Studies of the Her-2/neu protooncogene in human breast and ovarian carcinoma, Science 244, 707-712 (1989).
7. 7. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/neu oncogene, Science 235, 177-181 (1987).
8. 8. Singleton, T. P., and Strickler, J. G. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene, Pathol. Annu. 235, 156-190 (1992).
9. 9. Tanner, B., Friedberg, T., Mitze, M., Beck, T., Oesch, F., and Knapstein, P. G. C-erbB-2 oncogene expression in breast carcinoma -Analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters, Gynecol. Oncol. 47, 228-233 (1992).
10. 10. Muss, H. B., Thor, A. D., Berry, D. A., Kute, T., Liu, E. T., Koerner, F., Cirrincione, C. T., Budman, D. R., Wood, W. C., Barcos, M., and Henderson, I. G. C-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer, N. Engl. J. Med. 330, 1260-1266 (1994).
11. 11. Press, M. F., Jones, L. A., Godolphin, W., Edwards, C. L., and Slamon, D. J. Her-2/neu oncogene amplification and expression in breast and ovarian cancers, Frog Clin. Biol. Res. 254A, 209-221 (1990).
12. 12. Berchuck, A., Kamel, A., Whitaker, R., Kerns, B., Olt, G., Kinney, R., Soper, J. T., Dodge, R., Clarke-Pearson, D. L., Marks, S., McKenzie, S., and Bast, R. C., Jr. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer, Cancer Res. 50, 4087-4091 (1990).
13. 13. Haldane, J. S., Hird, V., Hughes, C. M., and Gullick, W. J. C-erbB-2 oncogene expression in ovarian cancer, J. Pathol. 162, 231-237 (1990).
14. 14. Singleton, T. P., Perrone, T., Oakley, G., Niehans, G. A., Carson, L., Cha, S. S., and Strickler, J. G. Activation of c-erbB-2 and prognosis in ovarian carcinoma, Cancer 73, 1460-1466 (1994).
15. 15. Serov, S. F., Scully, R. E., and Sobin, L. H. International histologic classification of tumours, no. 9. Histologic typing of ovarian tumours. Geneva, World Helth Organization (1973).
16. 16. Czernobilsky, B. Common epithelial tumors of the ovary, in Blausteins pathology of the female genital tract (R. J. Kurman, Ed.), Springer-Verlag, New York, pp. 560-607 (1987).
17. 17. Classification and staging of malignant tumours in the female pelvis, Acta Obstet. Gynecol. Scand. 50, 1-7 (1971).
18. 18. Myers, R. M., Larin, Z., and Maniatis, T. Detection of single base substitutions by ribonuclease clevage at mismatches in RNA:RNA duplexes, Science 230, 1242-1246 (1985).
19. 19. Krieg, P. A., and Melton, D. A. Functional messenger RNA's are produced by SP6 transcription of cloned cDNA's, Nucleic Acids Res. 12, 7057-7070 (1984).
20. 20. Kraus, M. H., Larin, Z., Amsbough, S. C., and Xing, C. R. Overexpression of the EGF receptor-related proto-oncogenes c-erbB-2 in human mammary tumor cell lines by different molecular mechanisms, EMBO J. 6, 605-610 (1987).
21. 21. SAS Institute Inc. SAS/STAT user's guide, Ver. 6, Vols. 1 and 2, 4th ed., SAS Insitute Inc., Cary, NC (1990).
22. 22. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
23. 23. Huettner, P. C., Carney, W. P., Naber, S. P., DeLellis, R. A., Membrino, W., and Wolfe, H. J. Neu oncogene expression in ovarian tumors: A quantitative study, Mod. Pathol. 5, 250-256 (1992).
24. 24. Tyson, F. L., Boyer, C. M., Kaufmann, R., O'Briant, K., Cram, G., Crews, J. R., Soper, J. T., Daly, L., Fowler, W. C., Jr., Haskill, J. S., and Bast, R. C., Jr. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelian ovarian tumors and cell lines, Am. J. Obstet. Gynecol. 165, 640-646 (1991).
25. 25. Garuti, G., and Gennazzani, A. R. Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas, Cancer 67, 1713 (1991). [Letter].
26. 26. Hung, M.-C., Zhang, X., Yan, D.-H., Zhang, H.-Z., He, G.-P. Zhang, T.-Q., and Shi, D.-R. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer, Cancer Lett. 61, 95-103 (1992).
27. 27. Zheng, J., Robinson, W. R., Ehlen, T., Yu, M. C., and Dubeau, L. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER/neu gene amplification, Cancer Res. 51, 4045-4051 (1991).
28. 28. Kury, F. D., Schneeberger, C., Sliutz, G., Kubista, E., Salzer, H., Medl, M., Leodolter, S., Swoboda, H., Zeilinger, R., Spona, J. Determination of HER-1/neu amplification and expression in tumor tissue and cultured cells using a simple phenol free method for nucleic acid isolation, Oncogene 5, 1403-1408 (1990).
29. 29. Gallion, H. H., Powell, D. E., Smith, L. W., Merrow, J. K., Martin, A. W., van Nagell, J. R., and Donaldson, E. S. Chromosome abnormalities in human epithelial ovarian malignancies, Gynecol. Oncol. 38, 473-477 (1990).
30. 30. Kacinski, B. M., Mayer, A. G., King, B. L., Carter, D., and Chambers, S. K. NEU protein overexpression in benign, borderline, and malignant ovarian neoplasm, Gynecol. Oncol. 44, 245-253 (1992).
31. 31. Seidmann, J. D., Frisman, D. M., and Norris, H. J. Expression of the HER-2/neu proto-oncogene in serous ovarian neoplasm, Cancer 70, 2857-2860 (1992).
32. 32. Meden, H., Marx, D., Rath, H., Kuhn, W., Hinney, B., and Schauer, A. Overexpression of c-erbB-2 oncogene in primary ovarian cancers: Incidence and prognostic significance in 243 patients, Geburtshilfe Frauenheilk 52, 667-673 (1992).
33. 33. Mileo, A. M., Fanuele, M., Battaglia, F., Scambia, G., Benedetti-Panici, C., Mattei, C., Manucuso, S., and Delphio, A. Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries, Int. J. Biol. Markers 7, 47-51 (1992).
34. 34. Hruza, C., Dobianer, K., Beck, A., Czerwenka, K., Hanak, H., Klein, M., Leodolter, S., Medl, M., Müllauer-Ertl, S., Preiser, J., Rosen, A., Salzer, H., Sevelda, P., and Spora, J. HER-2 and INT-2 amplification by quantitative PCR in paraffin-embedded ovarian cancer tissue samples, Eur. J. Cancer 29A, 1593-1597 (1993).
35. 35. Rubin, S. C., Finsland, C. L., Wong, G. Y., Almadrones, L., Plante, M., and Lloyd, K. O. Prognostic significance of HER-2/neu in advanced ovarian cancer: A multivariate analysis, Am. J. Obstet. Gynecol. 168, 162-169 (1993).
36. 36. Sasano, H., Garett, C. T., Wilkenson, D. S., Silverberg, S., Comerford, J., and Hyde, J. Protooncogene amplification and tumor ploidy in human ovarian neoplams, Hum. Pathol. 21, 382-391 (1990).
37. 37. Richardson, G. S., Scully, R. E., Nikrui, N., and Nelson, J. H., Jr. Common epithelial cancer of the ovary, N. Engl. J. Med. 312, 415-424 (1985).
38. 38. Aure, J. C., Høeg, K., and Kolstad, P. Clinical and histologic studies of ovarian carcinoma: Long-term follow-up of 990 cases, Obstet. Gynecol. 37, 1-9 (1971).
39. 39. Hoskins, W. J., McGuire, W. P., Brady, M. F., Homesley, H. D., Creasman, W. T., Berman, M., Ball, H., and Berek, J. S. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma, Am. J. Obstet. Gynecol. 170, 974-980 (1994).